This is the authors' abstract. We don't add key points for this paper.
The aim of this study was to evaluate the real-life efficacy of pangenotypic antivirals in HIV-HCV-positive patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Piekarska et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: